Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72,127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S, Zhang W, Ni W, Xiao Z, Wang Q, Zhou Z, Feng Q, Zhang H, Chen D, Liang J, Lv J, Hui Z, He J, Gao S, Sun K, Fang D, Liu X, Li Y. Yu S, et al. Among authors: wang q. Radiother Oncol. 2019 Nov;140:159-166. doi: 10.1016/j.radonc.2019.06.020. Epub 2019 Jul 11. Radiother Oncol. 2019. PMID: 31302346
Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm, Prospective, Open-Label, Phase II Clinical Trial (TR-EAT).
Wu L, Wang Y, Li B, Wan G, Liang L, Li T, Lang J, Wang Q. Wu L, et al. Among authors: wang y, wang q. Front Oncol. 2022 Apr 8;12:878851. doi: 10.3389/fonc.2022.878851. eCollection 2022. Front Oncol. 2022. PMID: 35463350 Free PMC article.
Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study.
He W, Wang C, Wu L, Wan G, Li B, Han Y, Li H, Leng X, Du K, Chen H, Wang Q, Peng L. He W, et al. Among authors: wang c, wang q. Front Immunol. 2022 Jun 2;13:853922. doi: 10.3389/fimmu.2022.853922. eCollection 2022. Front Immunol. 2022. PMID: 35720312 Free PMC article.
72,127 results
You have reached the last available page of results. Please see the User Guide for more information.